Ask AI
ProCE Banner Activity

Phase II JAVELIN Bladder Medley: Interim Analysis of 1L Maintenance Therapy With Avelumab + Sacituzumab Govitecan vs Avelumab for Advanced Urothelial Carcinoma

Conference Coverage
Slideset

Interim analysis of the phase II JAVELIN Bladder Medley trial suggests that patients with advanced urothelial carcinoma without progression on first-line platinum-based chemotherapy achieve improved PFS with sacituzumab govitecan plus avelumab vs avelumab alone as maintenance therapy.

Released: June 10, 2025

Expiration: December 09, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Astellas.

Astellas